Concepts (282)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 34 | 2024 | 696 | 6.260 |
Why?
|
| Neuropsychological Tests | 40 | 2024 | 1145 | 4.090 |
Why?
|
| Dementia | 12 | 2024 | 476 | 2.930 |
Why?
|
| Deep Brain Stimulation | 13 | 2021 | 403 | 2.860 |
Why?
|
| Cultural Competency | 5 | 2023 | 70 | 2.820 |
Why?
|
| Cognitive Dysfunction | 9 | 2023 | 327 | 2.450 |
Why?
|
| Cognition Disorders | 9 | 2011 | 762 | 1.190 |
Why?
|
| Language | 8 | 2023 | 326 | 1.030 |
Why?
|
| Alzheimer Disease | 3 | 2021 | 818 | 0.920 |
Why?
|
| Pallidotomy | 3 | 2008 | 11 | 0.910 |
Why?
|
| Memory | 6 | 2023 | 445 | 0.900 |
Why?
|
| Amyotrophic Lateral Sclerosis | 7 | 2018 | 162 | 0.900 |
Why?
|
| Globus Pallidus | 7 | 2014 | 67 | 0.840 |
Why?
|
| Verbal Behavior | 4 | 2010 | 61 | 0.840 |
Why?
|
| Memory Disorders | 7 | 2020 | 288 | 0.810 |
Why?
|
| Neuropsychology | 2 | 2023 | 33 | 0.800 |
Why?
|
| Movement Disorders | 2 | 2021 | 236 | 0.780 |
Why?
|
| Subthalamic Nucleus | 4 | 2021 | 58 | 0.750 |
Why?
|
| Semantics | 2 | 2019 | 55 | 0.710 |
Why?
|
| Neurosurgery | 1 | 2021 | 118 | 0.690 |
Why?
|
| Cues | 2 | 2019 | 203 | 0.680 |
Why?
|
| Language Tests | 1 | 2019 | 26 | 0.660 |
Why?
|
| Temporal Lobe | 3 | 2010 | 191 | 0.570 |
Why?
|
| Cognition | 9 | 2022 | 969 | 0.550 |
Why?
|
| Verbal Learning | 4 | 2011 | 84 | 0.500 |
Why?
|
| Pandemics | 3 | 2021 | 1610 | 0.440 |
Why?
|
| Functional Laterality | 9 | 2009 | 277 | 0.430 |
Why?
|
| Quality of Life | 7 | 2024 | 4775 | 0.430 |
Why?
|
| Aged | 42 | 2024 | 73382 | 0.420 |
Why?
|
| Speech Disorders | 1 | 2012 | 85 | 0.390 |
Why?
|
| Humans | 75 | 2024 | 270802 | 0.390 |
Why?
|
| Depression | 5 | 2021 | 1733 | 0.390 |
Why?
|
| Telemedicine | 4 | 2021 | 552 | 0.370 |
Why?
|
| Mental Recall | 1 | 2011 | 171 | 0.360 |
Why?
|
| Speech Articulation Tests | 1 | 2010 | 8 | 0.360 |
Why?
|
| Disease Progression | 8 | 2024 | 6855 | 0.340 |
Why?
|
| Mental Processes | 3 | 2011 | 53 | 0.340 |
Why?
|
| Pilot Projects | 5 | 2020 | 2848 | 0.340 |
Why?
|
| Frontal Lobe | 1 | 2010 | 167 | 0.330 |
Why?
|
| Postoperative Complications | 6 | 2009 | 5676 | 0.330 |
Why?
|
| Activities of Daily Living | 6 | 2022 | 553 | 0.320 |
Why?
|
| Male | 44 | 2024 | 128397 | 0.280 |
Why?
|
| Female | 45 | 2024 | 148967 | 0.270 |
Why?
|
| Middle Aged | 34 | 2024 | 90347 | 0.260 |
Why?
|
| Parkinsonian Disorders | 2 | 2018 | 81 | 0.230 |
Why?
|
| Forecasting | 3 | 2023 | 702 | 0.230 |
Why?
|
| Anterior Temporal Lobectomy | 3 | 2009 | 34 | 0.230 |
Why?
|
| Movement | 1 | 2007 | 562 | 0.230 |
Why?
|
| Depressive Disorder | 1 | 2008 | 565 | 0.220 |
Why?
|
| Occupational Therapy | 1 | 2024 | 48 | 0.220 |
Why?
|
| Brain | 4 | 2016 | 4213 | 0.220 |
Why?
|
| Translations | 1 | 2023 | 43 | 0.220 |
Why?
|
| Multimorbidity | 1 | 2023 | 19 | 0.220 |
Why?
|
| Vietnam | 1 | 2023 | 65 | 0.220 |
Why?
|
| Translating | 1 | 2023 | 45 | 0.220 |
Why?
|
| Mood Disorders | 2 | 2018 | 163 | 0.220 |
Why?
|
| Republic of Korea | 1 | 2023 | 76 | 0.220 |
Why?
|
| Culturally Competent Care | 1 | 2023 | 50 | 0.210 |
Why?
|
| Disabled Persons | 1 | 2024 | 110 | 0.210 |
Why?
|
| Motivation | 2 | 2018 | 516 | 0.200 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2003 | 111 | 0.200 |
Why?
|
| Implantable Neurostimulators | 1 | 2021 | 18 | 0.200 |
Why?
|
| Quarantine | 1 | 2021 | 23 | 0.200 |
Why?
|
| Walking Speed | 1 | 2021 | 17 | 0.190 |
Why?
|
| HIV Seropositivity | 1 | 2001 | 155 | 0.180 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 5923 | 0.180 |
Why?
|
| Psychomotor Performance | 3 | 2014 | 239 | 0.180 |
Why?
|
| Behavioral Symptoms | 1 | 2020 | 27 | 0.170 |
Why?
|
| Frontotemporal Dementia | 2 | 2010 | 38 | 0.170 |
Why?
|
| Gait | 2 | 2021 | 159 | 0.170 |
Why?
|
| Wearable Electronic Devices | 1 | 2021 | 115 | 0.160 |
Why?
|
| Visual Perception | 2 | 2011 | 150 | 0.160 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 168 | 0.160 |
Why?
|
| Frailty | 1 | 2021 | 133 | 0.160 |
Why?
|
| Analysis of Variance | 5 | 2018 | 2320 | 0.150 |
Why?
|
| Stereotypic Movement Disorder | 1 | 2018 | 13 | 0.150 |
Why?
|
| United States | 8 | 2023 | 15855 | 0.150 |
Why?
|
| Feasibility Studies | 3 | 2022 | 2363 | 0.150 |
Why?
|
| Restless Legs Syndrome | 1 | 2018 | 22 | 0.150 |
Why?
|
| Electrodes, Implanted | 2 | 2009 | 186 | 0.150 |
Why?
|
| Postoperative Care | 1 | 2021 | 728 | 0.150 |
Why?
|
| Cohort Studies | 5 | 2024 | 9474 | 0.140 |
Why?
|
| Treatment Outcome | 12 | 2017 | 33741 | 0.140 |
Why?
|
| Hippocampus | 1 | 2003 | 973 | 0.140 |
Why?
|
| Emotions | 2 | 2011 | 560 | 0.140 |
Why?
|
| Preoperative Care | 2 | 2021 | 1567 | 0.140 |
Why?
|
| Aged, 80 and over | 13 | 2022 | 31008 | 0.140 |
Why?
|
| Executive Function | 3 | 2014 | 145 | 0.130 |
Why?
|
| Anxiety | 2 | 2015 | 1236 | 0.130 |
Why?
|
| Irritants | 1 | 1995 | 8 | 0.130 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 2057 | 0.130 |
Why?
|
| Erythema | 1 | 1995 | 48 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2019 | 572 | 0.120 |
Why?
|
| Neurocognitive Disorders | 1 | 2015 | 76 | 0.120 |
Why?
|
| Genetic Testing | 1 | 2023 | 1697 | 0.120 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2014 | 39 | 0.110 |
Why?
|
| Compulsive Behavior | 1 | 2014 | 40 | 0.110 |
Why?
|
| Edema | 1 | 1995 | 263 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2023 | 4831 | 0.110 |
Why?
|
| Educational Status | 2 | 2012 | 392 | 0.110 |
Why?
|
| Aging, Premature | 1 | 2013 | 39 | 0.110 |
Why?
|
| Tetraspanins | 1 | 2013 | 41 | 0.110 |
Why?
|
| Exercise | 2 | 2022 | 1207 | 0.110 |
Why?
|
| Exercise Therapy | 3 | 2022 | 293 | 0.110 |
Why?
|
| Medication Adherence | 2 | 2015 | 513 | 0.110 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 61 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2018 | 822 | 0.110 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 681 | 0.100 |
Why?
|
| Life Style | 1 | 2016 | 618 | 0.100 |
Why?
|
| Language Development Disorders | 1 | 2013 | 166 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 920 | 0.100 |
Why?
|
| Antiparasitic Agents | 1 | 2012 | 36 | 0.100 |
Why?
|
| Hypotension, Orthostatic | 1 | 2011 | 18 | 0.100 |
Why?
|
| Motor Activity | 2 | 2011 | 712 | 0.100 |
Why?
|
| Follow-Up Studies | 7 | 2014 | 15212 | 0.100 |
Why?
|
| Levodopa | 1 | 2012 | 94 | 0.100 |
Why?
|
| Space Perception | 2 | 2009 | 74 | 0.100 |
Why?
|
| Language Disorders | 2 | 2009 | 25 | 0.100 |
Why?
|
| Comorbidity | 4 | 2019 | 2392 | 0.090 |
Why?
|
| Prospective Studies | 4 | 2024 | 13417 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 4375 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 483 | 0.090 |
Why?
|
| Sneddon Syndrome | 1 | 2010 | 3 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 6193 | 0.090 |
Why?
|
| Patient Admission | 1 | 2012 | 231 | 0.090 |
Why?
|
| Demography | 1 | 2011 | 433 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2013 | 909 | 0.090 |
Why?
|
| Retrospective Studies | 7 | 2021 | 39832 | 0.090 |
Why?
|
| Behavior | 1 | 2010 | 100 | 0.090 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 220 | 0.090 |
Why?
|
| Geriatric Assessment | 1 | 2011 | 290 | 0.090 |
Why?
|
| Dominance, Cerebral | 1 | 2009 | 75 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2013 | 7895 | 0.080 |
Why?
|
| Automation | 1 | 2010 | 154 | 0.080 |
Why?
|
| Reference Values | 1 | 2011 | 1134 | 0.080 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2009 | 6 | 0.080 |
Why?
|
| Residence Characteristics | 1 | 2011 | 357 | 0.080 |
Why?
|
| Age of Onset | 4 | 2013 | 853 | 0.080 |
Why?
|
| Spinal Puncture | 1 | 2009 | 62 | 0.080 |
Why?
|
| Chorea | 1 | 2009 | 43 | 0.080 |
Why?
|
| Specialization | 1 | 2010 | 127 | 0.080 |
Why?
|
| Adult | 15 | 2020 | 81997 | 0.080 |
Why?
|
| Memory, Short-Term | 1 | 2009 | 154 | 0.080 |
Why?
|
| Disability Evaluation | 1 | 2009 | 237 | 0.080 |
Why?
|
| Aging | 1 | 2016 | 1550 | 0.080 |
Why?
|
| Stereotaxic Techniques | 2 | 1999 | 184 | 0.070 |
Why?
|
| Huntington Disease | 1 | 2009 | 149 | 0.070 |
Why?
|
| Reaction Time | 1 | 2008 | 238 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2010 | 1076 | 0.070 |
Why?
|
| Neurologic Examination | 1 | 2008 | 263 | 0.070 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2006 | 19 | 0.070 |
Why?
|
| Unemployment | 1 | 2006 | 33 | 0.070 |
Why?
|
| Patch Tests | 2 | 1997 | 7 | 0.070 |
Why?
|
| Base Sequence | 1 | 2013 | 5437 | 0.070 |
Why?
|
| Affective Symptoms | 1 | 2006 | 87 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 517 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2010 | 590 | 0.060 |
Why?
|
| Prevalence | 3 | 2020 | 3402 | 0.060 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2024 | 32 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2015 | 6768 | 0.060 |
Why?
|
| Speech Therapy | 1 | 2024 | 13 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 1431 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 907 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 76 | 0.050 |
Why?
|
| Taiwan | 1 | 2023 | 99 | 0.050 |
Why?
|
| Vocabulary | 1 | 2003 | 27 | 0.050 |
Why?
|
| Sclerosis | 1 | 2003 | 76 | 0.050 |
Why?
|
| Reward | 1 | 2004 | 176 | 0.050 |
Why?
|
| HIV Infections | 1 | 2015 | 2155 | 0.050 |
Why?
|
| Brazil | 1 | 2023 | 172 | 0.050 |
Why?
|
| Phonetics | 1 | 2003 | 49 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 1689 | 0.050 |
Why?
|
| Reoperation | 1 | 2007 | 1392 | 0.050 |
Why?
|
| Software | 1 | 2010 | 1356 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2010 | 2238 | 0.050 |
Why?
|
| Hospitalization | 1 | 2012 | 2168 | 0.050 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 3243 | 0.050 |
Why?
|
| Neurologists | 1 | 2021 | 19 | 0.050 |
Why?
|
| Neurosurgeons | 1 | 2021 | 17 | 0.050 |
Why?
|
| Veterans | 2 | 2012 | 1740 | 0.050 |
Why?
|
| China | 1 | 2023 | 635 | 0.050 |
Why?
|
| CD4 Antigens | 1 | 2001 | 170 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2018 | 1571 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2003 | 667 | 0.050 |
Why?
|
| Time Factors | 3 | 2008 | 13021 | 0.040 |
Why?
|
| Canada | 1 | 2021 | 440 | 0.040 |
Why?
|
| Speech Perception | 1 | 2001 | 73 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2021 | 418 | 0.040 |
Why?
|
| Thalamic Nuclei | 1 | 1999 | 27 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 273 | 0.040 |
Why?
|
| Survival Rate | 2 | 2010 | 12527 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 5778 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 1417 | 0.040 |
Why?
|
| Motor Skills | 1 | 1999 | 111 | 0.040 |
Why?
|
| Walking | 1 | 2021 | 269 | 0.040 |
Why?
|
| Hospitals, Veterans | 2 | 2012 | 371 | 0.040 |
Why?
|
| Attention | 2 | 2010 | 286 | 0.040 |
Why?
|
| Social Class | 1 | 2019 | 323 | 0.040 |
Why?
|
| Affect | 1 | 1999 | 305 | 0.040 |
Why?
|
| Cetrimonium Compounds | 1 | 1995 | 7 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1995 | 21 | 0.030 |
Why?
|
| Sodium Hydroxide | 1 | 1995 | 17 | 0.030 |
Why?
|
| Cyclohexenes | 1 | 1995 | 11 | 0.030 |
Why?
|
| Time | 1 | 2016 | 183 | 0.030 |
Why?
|
| Caregivers | 1 | 2022 | 753 | 0.030 |
Why?
|
| Ethanolamines | 1 | 1995 | 37 | 0.030 |
Why?
|
| Acetic Acid | 1 | 1995 | 33 | 0.030 |
Why?
|
| Terpenes | 1 | 1995 | 40 | 0.030 |
Why?
|
| Risk Factors | 2 | 2024 | 17900 | 0.030 |
Why?
|
| Acetates | 1 | 1995 | 122 | 0.030 |
Why?
|
| Allergens | 1 | 1997 | 252 | 0.030 |
Why?
|
| Postural Balance | 1 | 2016 | 140 | 0.030 |
Why?
|
| Telephone | 1 | 2015 | 159 | 0.030 |
Why?
|
| Acute Disease | 1 | 2019 | 2496 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 658 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 797 | 0.030 |
Why?
|
| Neurons | 1 | 2004 | 2454 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 188 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 2251 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2015 | 602 | 0.030 |
Why?
|
| Databases, Bibliographic | 1 | 2012 | 25 | 0.030 |
Why?
|
| Health Surveys | 1 | 2014 | 400 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 558 | 0.020 |
Why?
|
| Patient Selection | 1 | 1999 | 2026 | 0.020 |
Why?
|
| Logistic Models | 2 | 2009 | 3448 | 0.020 |
Why?
|
| Pharmaceutical Services | 1 | 2012 | 36 | 0.020 |
Why?
|
| Adolescent | 3 | 2006 | 32743 | 0.020 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2012 | 201 | 0.020 |
Why?
|
| Medication Errors | 1 | 2012 | 189 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2010 | 148 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 986 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 5060 | 0.020 |
Why?
|
| Exons | 1 | 2013 | 1381 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 1 | 2009 | 39 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 197 | 0.020 |
Why?
|
| Pharmacy Service, Hospital | 1 | 1989 | 58 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 591 | 0.020 |
Why?
|
| Geriatrics | 1 | 2010 | 90 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2010 | 218 | 0.020 |
Why?
|
| Pedigree | 1 | 2013 | 2042 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 200 | 0.020 |
Why?
|
| Neurology | 1 | 2010 | 120 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2010 | 223 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 4498 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 1265 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 361 | 0.020 |
Why?
|
| Child | 2 | 2013 | 30546 | 0.020 |
Why?
|
| Face | 1 | 2009 | 252 | 0.020 |
Why?
|
| Body Composition | 1 | 2010 | 607 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2010 | 366 | 0.020 |
Why?
|
| Outpatients | 1 | 2010 | 463 | 0.020 |
Why?
|
| Learning | 1 | 2010 | 431 | 0.020 |
Why?
|
| Psychiatry | 1 | 2010 | 276 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 2394 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 6686 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 2573 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 1313 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 1989 | 466 | 0.020 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2009 | 661 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 2311 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 3478 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 825 | 0.010 |
Why?
|
| Seizures | 1 | 2008 | 1036 | 0.010 |
Why?
|
| Genotype | 1 | 2010 | 4255 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 1174 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 5171 | 0.010 |
Why?
|
| Motor Skills Disorders | 1 | 2000 | 18 | 0.010 |
Why?
|
| Young Adult | 2 | 2010 | 22225 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 1988 | 0.010 |
Why?
|
| Microelectrodes | 1 | 1998 | 54 | 0.010 |
Why?
|
| Hemiplegia | 1 | 1998 | 48 | 0.010 |
Why?
|
| Obesity | 1 | 2010 | 2905 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 17048 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1998 | 190 | 0.010 |
Why?
|
| Reference Standards | 1 | 1997 | 368 | 0.010 |
Why?
|
| Algorithms | 1 | 2004 | 3900 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1989 | 19 | 0.010 |
Why?
|
| San Francisco | 1 | 1989 | 24 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1989 | 310 | 0.000 |
Why?
|
| Medical Records | 1 | 1989 | 442 | 0.000 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1989 | 1073 | 0.000 |
Why?
|
| Animals | 1 | 2004 | 62048 | 0.000 |
Why?
|